Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.31419 ↗At a glance
Beobachtungsstudie in Catheterization and Cardiovascular Interventions, 2025. Written by Xuguang Zhang and 6 co-authors. Institution: Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China. Major MEDLINE topics: Acute Coronary Syndrome, Blood Platelets, Platelet Activation. Cited 1 times so far (Crossref); 22 references. Funded by: This study was supported by the Industry-Learning-Research Innovation Funding of the Chinese Ministry of Education-Huatong Guokang Medical Scientific Research….
Abstract (original language)
Background
Platelet activation plays a central role in the pathogenesis of acute coronary syndrome (ACS). Platelet morphological parameters, including MPV, PDW, and P‐LCR, are emerging as biomarkers for predicting the severity of ACS and prognosis.
Aims
This study aims to assess the relationship between these parameters and coronary severity and to evaluate their predicting adverse outcomes.
Methods
A total of 134 ACS patients and 50 healthy controls were included in this prospective observational study. Platelet morphological parameters (MPV, PDW, and P‐LCR) were measured at admission, and coronary artery lesion severity was determined using the Gensini score from coronary angiography. Multivariate logistic regression analysis assessed the predictive value of these platelet parameters for adverse outcomes, and ROC curve analysis was used to evaluate their diagnostic performance.
Results
MPV, PDW, and P‐LCR were significantly higher in ACS patients compared to healthy controls ( p < 0.001). A strong positive correlation was found between platelet parameters and the Gensini score (MPV: r = 0.778, PDW: r = 0.800, P‐LCR: r = 0.761; p < 0.001). Multivariate logistic regression identified MPV (OR = 1.807, p < 0.001), PDW (OR = 1.700, p = 0.001), and P‐LCR (OR = 1.287, p < 0.001) as independent predictors of advent prognosis. ROC curve analysis showed that the combined use of MPV, PDW, and P‐LCR provided superior predictive accuracy (AUC = 0.927) compared to the individual parameters.
Conclusion
Elevated platelet morphological parameters are strongly associated with coronary artery lesion severity and serve as independent predictors of adverse outcomes in ACS patients. The combined assessment of MPV, PDW, and P‐LCR enhances risk stratification, offering a valuable tool for guiding therapeutics and improving prognosis in management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Cardiology, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China.
- Department of Hematology and Oncology, The Children's Hospital of Jinan City, Shandong University, Jinan, Shandong, People's Republic of China.
- Department of Cardiology, The University of California Davis Medical Center, Sacramento, California, USA.
Funding
- This study was supported by the Industry-Learning-Research Innovation Funding of the Chinese Ministry of Education-Huatong Guokang Medical Scientific Research…
Cite
APA
Zhang, X., Huang, Z., Wang, X., Hao, H., Fan, D., Cadeiras, M., & Liu, Y. (2025). Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31419
Vancouver
Zhang X, Huang Z, Wang X, Hao H, Fan D, Cadeiras M, et al. Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31419
BibTeX
@article{Zhang2025,
author = {Zhang, Xuguang and Huang, Zhiwei and Wang, Xin and Hao, Han and Fan, Dali and Cadeiras, Martin and Liu, Yusheng},
title = {Analysis of Platelet Morphological Parameters as Clinical Risk Stratification in Acute Coronary Syndrome},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.31419}
}
EUVIMED